Cradle Bio
AI for protein engineering.
About Cradle Bio
ML-driven protein design platform. Helps biotech companies design new proteins faster — for biofuels, materials, and therapeutics.
Pitch deck breakdown
How Cradle Bio would pitch themselves.
Target customer
Protein engineering — the core audience Cradle Bio's product is built around.
Problem they solve
ML-driven protein design platform. Helps biotech companies design new proteins faster — for biofuels, materials, and therapeutics. The category has historically been served by tools that miss the modern workflow this product is built around.
Key differentiator
Cradle Bio differentiates on ai for protein engineering. Backed by IVP + Index Ventures, $78M+ raised — the company has resources + validation to compound this thesis. Founded by Stef van Grieken + team.
Go-to-market strategy
Growth-stage GTM — multi-channel revenue motion (direct enterprise sales, channel partnerships, marketplace listings). Vertical specialisation + verticalised AE teams targeting enterprise + mid-market.
Company facts
- Category
- Other
- Funding stage
- Series B
- Total raised
- $78M+
- Founded
- 2021
- Team size
- 51-200
- HQ
- Zurich
- Country
- Switzerland
- Website
- cradle.bio
Founders of Cradle Bio
- Stef van Grieken
- Jelle van der Hilst
Investors backing Cradle Bio
- IVP
- Index Ventures
Frequently asked questions
What does Cradle Bio do?
ML-driven protein design platform. Helps biotech companies design new proteins faster — for biofuels, materials, and therapeutics.
Where is Cradle Bio based?
Cradle Bio is based in Zurich, Switzerland.
When was Cradle Bio founded?
Cradle Bio was founded in 2021.
How much has Cradle Bio raised?
Cradle Bio has raised $78M+ in their Series B round.
Who founded Cradle Bio?
Cradle Bio was founded by Stef van Grieken, Jelle van der Hilst.
Who has invested in Cradle Bio?
Cradle Bio is backed by IVP, Index Ventures.